Ikarian Capital, LLC Ardelyx, Inc. Transaction History

Ikarian Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.23 - $4.95 $969,000 - $1.49 Million	-300,000 Reduced 51.83%	278,825 $945,000
Q1 2023 May 15, 2023	SELL	$2.68 - $4.79 $2.14 Million - $3.83 Million	-800,000 Reduced 58.02%	578,825 $2.77 Million
Q4 2022 Feb 14, 2023	SELL	$1.22 - $2.85 $2.2 Million - $5.13 Million	-1,800,000 Reduced 56.62%	1,378,825 $3.93 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $883,981 - $2.16 Million	1,498,273 Added 89.15%	3,178,825 $3.78 Million
Q2 2022 Aug 12, 2022	BUY	$0.51 - $1.17 $857,081 - $1.97 Million	1,680,552 New	1,680,552 $991,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $6.75 Million - $9.25 Million	-1,030,436 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $762,500 - $961,250	-125,000 Reduced 10.82%	1,030,436 $6.82 Million
Q4 2020 Feb 12, 2021	SELL	$5.05 - $7.1 $1.89 Million - $2.66 Million	-375,000 Reduced 24.5%	1,155,436 $7.48 Million
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $723,822 - $976,126	137,871 Added 9.9%	1,530,436 $8.04 Million
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $374,122 - $565,015	-69,669 Reduced 4.76%	1,392,565 $9.64 Million
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $3.55 Million - $7.18 Million	816,798 Added 126.55%	1,462,234 $8.31 Million
Q4 2019 Jan 31, 2020	BUY	$4.23 - $8.29 $2.73 Million - $5.35 Million	645,436 New	645,436 $4.84 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.